Challenges and Developments in Alzheimer's Treatment with Semaglutide

This chapter delves into the challenges and advancements related to oral semaglutide in the treatment of Alzheimer's disease, often termed type 3 diabetes. It emphasizes the complexities of drug development while expressing cautious optimism for upcoming data that could illuminate the potential benefits of semaglutide's anti-inflammatory effects.